Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results